An analysis of data on 120 low-income patients with advanced diabetic nephropathy and chronic kidney disease showed that 13% of those assigned to multifactorial intervention developed end-stage renal disease at two years, compared with 28% of those who received usual care. More patients in the intervention group also attained an HbA1C of less than 7% and showed greater declines in albumin:creatinine ratio and better lipid/blood pressure control than those in the control group, researchers reported at the American Diabetes Association 73rd Scientific Sessions.

Related Summaries